Home > Insider Trading > Filing (0001209191-10-023993)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1097136	Senorx Inc	SENO	Surgical & Medical Instruments & Apparatus (3841)	330787406

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1134655	Ansbert Gadicke	C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116	No	No	Yes	No
1134657	Luke Evnin	C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116	No	No	Yes	No
1166285	Michael Steinmetz	C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116	No	No	Yes	No
1252522	Nicholas Galakatos	C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116	No	No	Yes	No
1264824	Mpm Asset Management Investors 2001 Llc	C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116	No	No	Yes	No
1264826	Mpm Asset Management Ii Lp	C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116	No	No	Yes	No
1264827	Mpm Asset Management Ii Llc	C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116	No	No	Yes	No
1264829	Mpm Bioventures Ii Lp	C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116	No	No	Yes	No
1264830	Mpm Bioventures Ii Qp Lp	C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116	No	No	Yes	No
1264832	Mpm Bioventures Gmbh & Co Parallel Beteiligungs Kg	C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-04-26	1,000	$10.05	2,207,668	No	4	S	Indirect	See footnote
Common Stock	Disposition	2010-04-27	13,900	$10.09	2,193,768	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote

Footnotes

The shares were sold as follows: 674 by MPM BioVentures II-QP, L.P. ("BV II QP"), 75 by MPM BioVentures II, L.P. ("BV II"), 14 by MPM Asset Management Investors 2001 LLC ("AM 2001") and 237 by MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG ("BV KG"). MPM Asset Management II, L.P. ("AM II GP") and MPM Asset Management II LLC ("AM II LLC") are the direct and indirect general partners of BV II QP, BV II and BV KG. Luke Evnin, Ansbert Gadicke, Nicholas Galakatos, Michael Steinmetz and Kurt Wheeler are the members of AM II LLC and AM 2001.
The shares are held as follows: 1,488,412 by BV II QP, 164,250 by BV II, 30,906 by AM 2001 and 524,100 by BV KG. Each member of the group disclaims beneficial ownership of the securities except to the extent of his or its pecuniary interest therein.
The shares were sold as follows: 9,371 by BV II QP, 1,034 by BV II, 195 by AM 2001 and 3,300 by BV KG.
The shares are held as follows: 1,479,041 by BV II QP, 163,216 by BV II, 30,711 by AM 2001 and 520,800 by BV KG. Each member of the group disclaims beneficial ownership of the securities except to the extent of his or its pecuniary interest therein.